04:16 PM EDT, 03/17/2026 (MT Newswires) -- Kestra Medical Technologies ( KMTS ) reported a fiscal Q3 net loss late Tuesday of $0.61 per diluted share, narrowing from a loss of $1.25 a year earlier.

Analysts polled by FactSet expected a loss of $0.60.

Revenue for the quarter ended Jan. 31 was $24.6 million, up from $15.1 million a year earlier.

Analysts surveyed by FactSet expected $22.9 million.

For fiscal 2026, Kestra raised its revenue guidance to $93 million from $91 million. Analysts expect $90.9 million.